Type 2 diabetes
Conditions
Interventions
Sponsors
Dongzhimen Hospital of Beijing University of Chinese Medicine
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: (1) Aged 18-60 years old; (2) Clinically diagnosed with Type 2 diabetes mellitus with a course of less than 8 years. Fasting blood glucose < 7 mmol/L and HbA1c < 7% after drug intervention. (3) Presently receiving Western medicine treatment (with unlimited varieties and methods of medication). (4) The C-peptide levels of T2DM patients receiving insulin treatment should be greater than or equal to 0.2 nmol/L (0.6 ng/mL); (5) BMI < 25 kg/m2; (6) Systolic blood pressure < 160 mmHg and diastolic blood pressure < 100 mmHg in patients with hypertension; (7) Being able to follow the treatment, examination and follow-up plan; (8) Fully understand and voluntarily sign the informed consent.
Exclusion criteria
Exclusion criteria: (1) Abnormal liver and kidney functions. (2) Alcoholism, malignant tumors, epilepsy or mental disorders; (3) Diabetic complications; (4) Arrhythmia, cardiopulmonary disfunction or previous stent surgery; (5) With a pacemaker, hearing aid or other electronic or metal components; (6) Severe infections, infectious diseases and severe skin lesions; (7) Pregnant women, pregnancy preparation or lactating women; (8) Weight-loss surgery or gastrointestinal surgery; (9) Severe pathological changes of gallbladder, thyroid, kidney and other tissues or organs after operation; (10) Peptic ulcer; (11) Participating in other clinical studies; (12) Other reasons that can not cooperate with the study.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Fasting C-peptide;Fasting insulin;HbA1c;Fasting blood glucose; | — |
Secondary
| Measure | Time frame |
|---|---|
| SF-36 Health Survey;2 h postprandial blood glucose; | — |
Countries
China
Contacts
Public ContactGuoyong Yu
Dongzhimen Hospital of Beijing University of Chinese Medicine
Outcome results
None listed